Skip to main content
Study compares efficacy of NPH insulin, DPP-4 inhibitors in type 2 diabetes
5/17/2018

Researchers found that patients with type 2 diabetes who used neutral protamine Hagedorn insulin as a third-line therapy were more likely to discontinue its use and had an increased risk for hypoglycemia than those on DPP-4 inhibitors. The findings in the Journal of Diabetes Research, based on 54,318 patients, showed the groups had a similar risk for cardiovascular events.

Full Story: